Arterial spin labeling (ASL) offers a non-invasive and repeatable method for quantifying CBF, a promising biomarker in cancer imaging. However, the consensus for voxelwise calibration may not be appropriate for application in tumours. We hypothesise that voxelwise calibration in the presence of oedema will decrease sensitivity to alterations in CBF, and test this by measuring CBF with pseudocontinurous ASL in seven patients with glioblastoma multiforme, comparing the impact of voxelwise, white matter, and CSF calibration on tumour CBF. Calibration choice significantly affects absolute CBF; with a loss of CBF contrast in tumours when using voxelwise calibration, which may have clinical implication.
This abstract and the presentation materials are available to members only; a login is required.